1. Home
  2. MSA vs IBRX Comparison

MSA vs IBRX Comparison

Compare MSA & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSA Safety Incorporated

MSA

MSA Safety Incorporated

HOLD

Current Price

$186.36

Market Cap

7.3B

Sector

Health Care

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.99

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSA
IBRX
Founded
1914
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.2B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
MSA
IBRX
Price
$186.36
$7.99
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$197.40
$12.57
AVG Volume (30 Days)
190.6K
7.0M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
1.29%
N/A
EPS Growth
N/A
38.71
EPS
4.05
N/A
Revenue
$1,874,814,000.00
$113,288,000.00
Revenue This Year
$6.78
$88.59
Revenue Next Year
$5.00
$131.15
P/E Ratio
$46.60
N/A
Revenue Growth
3.69
668.31
52 Week Low
$151.11
$1.95
52 Week High
$208.92
$12.43

Technical Indicators

Market Signals
Indicator
MSA
IBRX
Relative Strength Index (RSI) 47.93 52.42
Support Level $185.81 $7.77
Resistance Level $192.41 $8.51
Average True Range (ATR) 3.57 0.35
MACD -0.87 0.01
Stochastic Oscillator 16.10 41.92

Price Performance

Historical Comparison
MSA
IBRX

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The company's product offerings include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems, among others. The end markets for its products include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company has organized its business into four geographical operating segments that are aggregated into two reportable segments: Americas and International. The majority of its revenue is generated from the Americas segment, which is comprised of the company's operations in Northern North America and Latin America geographies.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: